跳至主要内容
临床试验/NCT04859231
NCT04859231终止不适用

Nutritive Effects of Cow's Milk-Based Formulas Through 18 Months of Age

Mead Johnson Nutrition1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2021年8月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
1
试验地点
1
主要终点
MR Imaging

研究概览

简要总结

This clinical trial will assess nutritive effects on brain myelination in infants assigned to receive one of two study formula or mother's own breast milk through 18 month's of age.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
3 Days 至 180 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Singleton birth
  • Gestational age of 37-42 weeks (36 weeks and six days is considered 36 weeks gestational age)
  • Birth weight of 2500 g (5 lbs 8 oz) or more
  • Parent(s) or legal guardian agrees not to enroll infant in another interventional clinical study while participating in this study
  • Signed informed consent obtained for infant's participation in the study
  • Signed authorization obtained to use and/or disclose Protected Health Information for infant from birth through 18 months of age
  • Infants receiving formula:
  • 3 to 60 days of age at randomization, inclusive (day of birth is considered day 0)
  • Exclusively receiving infant formula for at least 72 hours prior to randomization
  • Parent(s) or legal guardian has full intention to exclusively feed study formula during the study period
  • Infants receiving human milk:
  • 150-180 days of age at registration, inclusive (day of birth is considered day 0)
  • Mother has intention to predominately provide mother's own breast milk through at least 10 months of age

排除标准

  • Contraindication to magnetic resonance imaging (MRI)
  • First degree relative with known autism, intellectual disability, schizophrenia, or bipolar disorder or an inherited disorder of myelination
  • Major pre- and/or perinatal issues (such as maternal pre-eclampsia, placental abruption, maternal alcohol or illicit drug use during pregnancy)
  • Major delivery complications (such as neonatal hypoxia or neonatal illness requiring a greater than 2-day NICU stay)
  • Infant is immunocompromised (according to a doctor's diagnosis of immunodeficiency such as combined immunodeficiencies, DiGeorge syndrome, Wiskott-Aldrich syndrome, severe congenital neutropenia and secondary immunodeficiencies linked to HIV infection, Down syndrome or others)
  • 5 minute APGAR < 7
  • Infant was born large for gestational age (LGA) (as confirmed by the hospital birth records) from mother who was diabetic at childbirth
  • Infant has been identified with inadequate weight gain or failure to thrive by a health care professional (HCP)
  • History of underlying metabolic or chronic disease; congenital malformation; or any other condition which, in the opinion of the Investigator, is likely to interfere with: the ability of the infant to ingest food, the normal growth and development of the infant, or the evaluation of the infant
  • Parent(s) or legal guardian unable to speak English at a level to provide informed consent
  • Infants receiving formula:
  • Evidence of feeding difficulties or history of formula intolerance, such as vomiting or poor intake at time of randomization
  • Infants receiving human milk:
  • Use of infant formula and/or donor milk more than three times per week prior to registration

研究组 & 干预措施

Control

Active Comparator

干预措施: Control (Other)

Investigational

Experimental

干预措施: Investigational (Other)

Mother's-own Breast Milk

No Intervention

结局指标

主要结局

MR Imaging

时间窗: 365 days of age

Brain Imaging

次要结局

  • MR Imaging(180 and 545 days of age)
  • Gap Overlap Paradigm(180 and 365 days of age)
  • Body Weight(180, 365 and 545 days of age)
  • Visual Expectation Paradigm(180 and 365 days of age)
  • Bayley Scales of Infant and Toddler Development, Third Edition(365 and 545 days of age)
  • Head Circumference(180, 365 and 545 days of age)
  • Stool Microbiome Composition(180, 365 and 545 days of age)
  • Medically confirmed Adverse Events(Through study completion, on average 18 months)
  • A-not-B Task(365 and 545 days of age)
  • Length(180, 365 and 545 days of age)
  • Recall of Study Feeding(180, 275 (HM Reference group only), 365 and 545 days of age)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验